Page last updated: 2024-11-13

coumatetralyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

coumatetralyl: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID54678504
CHEMBL ID3184636
CHEBI ID80742
SCHEMBL ID5933927
SCHEMBL ID137261
MeSH IDM0045840

Synonyms (67)

Synonym
AC-12689
racumin
coumarin, 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)-
einecs 227-424-0
bayer 25 634
endox
raucumin 57
2h-1-benzopyran-2-one, 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthalenyl)-
coumatetralyl [bsi:iso]
epa pesticide chemical code 496100
rodentin
ccris 6923
bay 25634
cumatetralyl [german, dutch]
endrocide
3-(d-tetralyl)-4-hydroxycoumarin
4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin
3-(alpha-tetralyl)-4-hydroxycoumarin
3-(1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycumarin [german]
4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)-cumarin
bay ene 11183 b
4-idrossi-3-(1,2,3,4-tetraidro-1-naftil)-cumarina [italian]
coumatetralyl
brn 1323631
4-hydroxy-3-(1,2,3,4-tetrahydro-1-naftyl)-cumarine [dutch]
hsdb 1725
4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthalenyl)-2h-1-benzopyran-2-one
3-(1,2,3,4-tetrahydro-1-naphtyl)-4-hydroxycoumarine [french]
ene 11183 b
3-(alpha-tetral)-4-oxycoumarin
caswell no. 496a
endrocid
5836-29-3
dtxsid8041799 ,
NCGC00255682-01
cas-5836-29-3
tox21_301252
dtxcid6021799
4-idrossi-3-(1,2,3,4-tetraidro-1-naftil)-cumarina
unii-nwk4hw86a8
3-(1,2,3,4-tetrahydro-1-naphtyl)-4-hydroxycoumarine
4-hydroxy-3-(1,2,3,4-tetrahydro-1-naftyl)-cumarine
cumatetralyl
3-(1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycumarin
nwk4hw86a8 ,
3-(1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin
AKOS015903266
SCHEMBL5933927
SCHEMBL137261
coumatetralyl [hsdb]
3-(.alpha.-tetralyl)-4-hydroxycoumarin
2h-1-benzopyran-2-one, 4-hydroxy-3-(1,2,3,4-tetrahydro-1- naphthalenyl)-
4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthalenyl)-2h-1- benzopyran-2-one
3-(.alpha.-tetral)-4-oxycoumarin
coumatetralyl [iso]
CHEBI:80742 ,
3-(1-tetralyl)-4-hydroxycoumarin
4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthalenyl)-2h-chromen-2-one #
ULSLJYXHZDTLQK-UHFFFAOYSA-N
coumetralyl
3-(1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarine
3-(.alpha.-tetralinyl)-4-hydroxycoumarin
CHEMBL3184636
4-hydroxy-3-(1,2,3,4-tetrahydronaphthalen-1-yl)-2h-chromen-2-one
coumatetralyl, pestanal(r), analytical standard
Q415772
4-hydroxy-3-(1,2,3,4-tetrahydronaphthalen-1-yl)chromen-2-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hydroxycoumarinAny coumarin carrying at least one hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency79.64070.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency48.55770.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency2.16900.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency48.96620.000221.22318,912.5098AID743035; AID743063
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency58.42540.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency30.63790.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency61.64480.000229.305416,493.5996AID743069
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency11.39100.001019.414170.9645AID743094; AID743140; AID743191
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency61.13060.000323.4451159.6830AID743065; AID743067
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency61.13060.000627.21521,122.0200AID743202
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (28.57)18.7374
1990's3 (14.29)18.2507
2000's5 (23.81)29.6817
2010's7 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.65 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index80.73 (26.88)
Search Engine Supply Index3.97 (0.95)

This Compound (32.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies3 (13.04%)4.05%
Observational0 (0.00%)0.25%
Other20 (86.96%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]